Schönfelder M, Hofmann H, Schulz T, Engl T, Kemper D, Mayr B, Rautenberg C, Oberhoffer R, Thieme D
Chair of Exercise Biology, Technical University of Munich, Germany.
Institute of Pathology, Technical University of Munich, Germany.
Drug Test Anal. 2016 Nov;8(11-12):1186-1196. doi: 10.1002/dta.2110. Epub 2016 Nov 9.
Administration of low amounts of endogenous hormones - so-called micro-dosages - are supposed to represent a major challenge in doping analysis. To model such a situation, we have studied transdermal administrations of 2.4 mg/24 h testosterone patches and examined various steroid concentrations in blood, urine, and saliva of 11 volunteers. Multiple samples were collected at t = 0, 3, 6, 9, 24, 48, and 72 h in four different phases, i.e., all combinations with/without physical exercise and with/without testosterone. Testosterone was analyzed by enzyme-linked-immuno-assay as well as by mass spectrometry and validated in an accredited anti-doping laboratory. Circadian controls with and without exercise did not provoke prominent alterations of whole, free, and salivary testosterone. Testosterone application for 24 h led to a significant (all p < 0.001) mean increase above controls: total testosterone (median: 5.2 vs. 8.0 ng/mL), free testosterone (median: 11.3 vs. 15.6 pg/mL), and salivary testosterone (median: 62.4 vs. 99.9 pg/mL). Additionally, all three testosterone measurements indicated significant correlations to each other (all r > 0.538, all p < .001). Circadian-matching showed peaking testosterone values after 6 h and 9 h, reaching highest augmentation up to 252.6 ± 123.5% in saliva after 9 h. After removal of the testosterone patch, all testosterone levels in blood, saliva, and urine returned to baseline within 24 h. Different techniques of hormone detection (enzyme-linked immunosorbent assay (ELISA), gas chromatography-tandem mass spectrometry (GC-MS/MS), liquid chromatography-tandem mass spectrometry (LC-MS/MS)) indicated significant correlations. Results indicate that saliva, blood, and urine exhibit comparable hormone augmentation during micro-dose testosterone application, indicating a possible consideration in future doping analysis. The inter-individual variability was high in all biofluids, requiring the use of an individual biological passport rather than statistical values. Copyright © 2016 John Wiley & Sons, Ltd.
给予低剂量的内源性激素——即所谓的微剂量——被认为是兴奋剂检测中的一项重大挑战。为模拟这种情况,我们研究了2.4毫克/24小时睾酮贴片的经皮给药,并检测了11名志愿者血液、尿液和唾液中的各种类固醇浓度。在四个不同阶段,即所有有/无体育锻炼以及有/无睾酮的组合情况下,于t = 0、3、6、9、24、48和72小时采集多个样本。通过酶联免疫吸附测定法以及质谱分析法对睾酮进行分析,并在一家获得认可的反兴奋剂实验室进行验证。有锻炼和无锻炼的昼夜节律对照并未引起总睾酮、游离睾酮和唾液睾酮的显著变化。应用睾酮24小时导致与对照组相比平均显著升高(所有p < 0.001):总睾酮(中位数:5.2对8.0纳克/毫升)、游离睾酮(中位数:11.3对15.6皮克/毫升)和唾液睾酮(中位数:62.4对99.9皮克/毫升)。此外,所有三项睾酮测量结果均显示彼此之间存在显著相关性(所有r > 0.538,所有p < 0.001)。昼夜节律匹配显示,睾酮值在6小时和9小时后达到峰值,9小时后唾液中最高增幅达252.6 ± 123.5%。移除睾酮贴片后,血液、唾液和尿液中的所有睾酮水平在24小时内恢复至基线。不同的激素检测技术(酶联免疫吸附测定法(ELISA)、气相色谱 - 串联质谱法(GC - MS/MS)、液相色谱 - 串联质谱法(LC - MS/MS))显示出显著相关性。结果表明,在微剂量睾酮应用期间,唾液、血液和尿液呈现出可比的激素增幅,这表明在未来的兴奋剂检测中可能需要考虑这一点。所有生物流体中的个体间变异性都很高,因此需要使用个体生物护照而非统计值。版权所有© 2016约翰威立父子有限公司。